It has been three weeks now since the pharma world met in Milan for the CPHI 2024. Three intensive days in this beautiful city were worth the efforts as they brought a lot of ideas to light, which we are now working on. The whole Transo-Pharm team enjoyed meeting up with our friends and partners – be it at a table at the Transo-Pharm booth or during our Happy Hour event with a glass of wine in our hands. We are already looking forward to seeing you all again in Frankfurt in 2025.
0 Comments
HAPILA and their distribution partner Transo-Pharm Handels GmbH have joined forces years ago in order to provide Estriol to more and more customers with high quality Estriol made in Germany. The collaboration entered into a new phase when we decided to expand capacity at the Hapila site in order to adequately supply the Estriol market. Consequently we made the decision to join forces at the CPhI Exhibition in Frankfurt and to integrate Hapila into the Transo-Pharm booth. A few recent updates on Estriol:
Looking forward to see you at CPHI in Frankfurt. Dear Customers, On May 25th we informed you about the fire accident at our Contract Manufacturer Syn-Tech in Taiwan. We are happy to inform you that the next production campaign for Epinephrine and Epinephrine bitartrate started – only 3 weeks after the incident. Thanks to the Syn-Tech colleagues for this tremendeous effort and excellent support during these difficult weeks. Needless to say, there are no delays in deliveries as we are still supplying the API’s from our stock in Hamburg/Germany.
Dear Customers, We regret to inform you that Syn-Tech Chem. & Pharm., Co Ltd. had a fire accident on May 20, 2021. Fortunately, nobody of the employees or the firefighters were injured. The production facility where Epinephrine and Epinephrine bitartrate are produced are not affected at all. The same applies to raw & starting material warehouse, finished product warehouse and QA/QC labs. Nevertheless, a detailed review and investigation is currently underway. Due to our extensive stockpiling program at our German site, Transo-Pharm can easely compensate such an event and can continue the supply of both API’s according to the existing demands and forecasts. Please be assured that we continuously keep you updated on the status at our partner in Taiwan.
|
Categories
All
Archives
October 2024
|